High-Intensity Lipid-Lowering Therapy After Complex Percutaneous Coronary Intervention
Korean Circulation Journal · 2027 · 57
DOI: 10.4070/kcj.2026.0064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Circulation Journal, 2027. Verfasst von Young-Kwan Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chong Kun Dang Inc..
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: We aimed to evaluate the association between high-intensity lipid-lowering therapy (HILLT) and long-term outcomes after percutaneous coronary intervention (PCI) across procedural complexity. METHODS: Post hoc observational cohort analysis of 3 drug-eluting stent registries (HOST-Onyx, HOST-Synergy, HOST-Alpine) was conducted. A total of 1,750 patients underwent PCI; 691 (39.5%) met criteria for complex PCI, defined as treatment of ≥3 stents implanted, ≥3 lesions treated, total stent length ≥60 mm, left main PCI, bifurcation PCI, or heavy calcification. The HILLT group was defined as those prescribed either high-intensity statins with or without ezetimibe, or moderate-intensity statins with ezetimibe. The primary outcome was major adverse cardio-cerebrovascular events (MACCE), composite of cardiac death, myocardial infarct, and stroke at 3 years. Multivariable Cox regression, propensity score (PS) matching, and inverse probability treatment weighting (IPTW) were used to adjust for confounding. RESULTS: Patients receiving HILLT exhibited a lower risk of MACCE (PS-matched hazard ratio [HR], 0.508; 95% confidence interval [CI], 0.260-0.994; p=0.048). Subgroup analysis revealed that this benefit was significant among patients undergoing complex PCI (HR, 0.292; 95% CI, 0.107-0.797; p=0.017) compared with the noncomplex PCI group (HR, 0.896; 95% CI, 0.346-2.322; p=0.822; p-for-interaction=0.107). Sensitivity analyses in the complex PCI subgroup demonstrated consistent results, with lower risk of MACCE in patients receiving HILLT (PS-matched HR, 0.320; 95% CI, 0.116-0.881; p=0.027; IPTW-adjusted HR, 0.246; 95% CI, 0.093-0.647; p=0.004). CONCLUSIONS: Among patients undergoing PCI, HILLT was associated with a lower 3-year risk of MACCE, with no significant interaction across procedural complexity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea.
- Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea. hpcrates@gmail.com.
ORCID-Profile: Young-Kwan Kim, Sang-Hyeon Park, Junpil Yun, Doyeon Hwang, Jeehoon Kang, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Jung-Kyu Han
Förderung
- Chong Kun Dang Inc.
Zitieren
APA
Kim, Y. K., Park, S. H., Yun, J., Hwang, D., Kang, J., Yang, H. M., Park, K. W., Kang, H. J., Koo, B. K., & Han, J. K. (2027). High-Intensity Lipid-Lowering Therapy After Complex Percutaneous Coronary Intervention. Korean Circulation Journal, 57. https://doi.org/10.4070/kcj.2026.0064
Vancouver
Kim YK, Park SH, Yun J, Hwang D, Kang J, Yang HM, et al. High-Intensity Lipid-Lowering Therapy After Complex Percutaneous Coronary Intervention. Korean Circulation Journal. 2027;57. doi:10.4070/kcj.2026.0064
BibTeX
@article{Kim2027,
author = {Kim, Young-Kwan and Park, Sang-Hyeon and Yun, Junpil and Hwang, Doyeon and Kang, Jeehoon and Yang, Han-Mo and Park, Kyung Woo and Kang, Hyun-Jae and Koo, Bon-Kwon and Han, Jung-Kyu},
title = {High-Intensity Lipid-Lowering Therapy After Complex Percutaneous Coronary Intervention},
journal = {Korean Circulation Journal},
year = {2027},
volume = {57},
doi = {10.4070/kcj.2026.0064}
}
EUVIMED